How IFN Signaling Tunes Macrophage Mitochondria in Inflammation Resolution
When our body fights an infection, the immune system must quickly activate defenses and trigger a beneficial inflammatory response. It’s just as important to be able to resolve that inflammation and return to homeostasis....
UVA Health scientists pioneer a new way to create vaccines far more quickly than...
UVA Health scientists are reporting promising success as they pioneer a new way to create vaccines far more quickly, nimbly and inexpensively than ever before. The University of Virginia School of Medicine's Steven L....
Eating beef as part of a healthy dietary pattern does not impact risk factors...
More than 135 million American adults are either living with or at risk for type 2 diabetes (T2D), elevating the need for more evidence-based dietary guidance to help this growing population achieve optimal health...
Insilico Medicine and Qilu Pharmaceutical partner to develop AI-designed cardiometabolic drugs
Insilico Medicine, a clinical-stage biotechnology company powered by generative AI, and Qilu Pharmaceutical Group, a major comprehensive modern pharmaceutical enterprise in China, as well as its subsidiary Shanghai Qilu Pharmaceutical Research Center, today announced...
Ex-CytoDyn CEO Sentenced to 30-Month Prison Term on Fraud, Insider Trading
Nader Z. Pourhassan, PhD, the former CEO of CytoDyn, was sentenced yesterday to 30 months in prison, more than a year after he was convicted on charges that included four counts of securities fraud, two...
Astoriom acquires Precision Stability Storage
Astoriom, a global leader in scientific research and consumer product sample stability and biorepository storage, has expanded its sample management capabilities in the US with the acquisition of Precision Stability Storage. This acquisition marks...
Blood protein albumin identified as key defense against deadly black fungus
A new international study published in Nature has identified albumin, the most abundant protein in human blood, as a powerful and previously unrecognized defense against mucormycosis, a rare but often fatal fungal infection. The research was led by George Chamilos,...
Clinical Ambitions: 10x Expands Beyond Research with Trio of Collaborations
With a trio of partnership announcements this month, 10x Genomics has signaled it is looking beyond its traditional focus on research tools for academic, government, and industry customers, by expanding into clinical diagnostics through...
AI-designed NLRP3 inhibitor receives FDA clearance for Parkinson disease trials
Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial intelligence (AI), today announced that ISM8969, an orally available NLRP3 inhibitor targeting inflammation and neurodegenerative disorders, has recently received investigational...
New AI-driven method enables precise design of highly efficient custom enzymes
Enzymes with specific functions are becoming increasingly important in industry, medicine and environmental protection. For example, they make it possible to synthesise chemicals in a more environmentally friendly way, produce active ingredients in a...
